Corrosive Esophagitis (Erosive Esophagitis) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Corrosive Esophagitis (Erosive Esophagitis) – Drugs In Development, 2024 report and make more profitable business decisions.
Erosive esophagitis is the damage caused to the tissue lining. It occurs because of the reflux of gastric contents into the stomach leading to mucosal injury. It is otherwise called as corrosive esophagitis whichis the severe form of gastroesophageal reflux disease (GERD).
The Corrosive Esophagitis (Erosive Esophagitis) drugs in development market research report provide comprehensive information on the therapeutics under development for Corrosive Esophagitis (Erosive Esophagitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Corrosive Esophagitis (Erosive Esophagitis) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Corrosive Esophagitis (Erosive Esophagitis) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 8 molecules, with 8 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Corrosive Esophagitis (Erosive Esophagitis) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Corrosive Esophagitis (Erosive Esophagitis) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Corrosive Esophagitis (Erosive Esophagitis) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Addpharma IncDaewoong Co Ltd
Luoxin Pharmaceuticals Group Stock Co Ltd
Onconic Therapeutics Co Ltd
Phathom Pharmaceuticals Inc
R-Pharm
Renexxion LLC
Sebela Pharmaceuticals Inc
Shanghai Haini Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Corrosive Esophagitis (Erosive Esophagitis) reports